Skip to main content

A discussion by Safir Anand on the laws and codes of practices governing advertising of medicinal products in India.

In India, pharmaceutical advertising is governed by The Drugs and Magic Remedies (Objectionable Advertisements) Act, 1954 and The Drugs and Cosmetics Rules, 1945. However these Acts do not lay down the minimum essential information requirements for advertisements. The Organization of Pharmaceutical Producers of India in its Code of Pharmaceutical Marketing Practices also provide guidelines for the information requirements in advertisements and the allowed practices for the promotion of pharmaceutical products. The Indian department of Pharmaceuticals has also come up with a Code of Marketing Practice for Indian Pharmaceutical Industry which is a voluntary code of Marketing Practices for Indian Pharmaceutical Industry.

This chapter was published in ICLG’s Pharmaceutical Advertising 2013.

To continue reading, please contact us at email@anandandanand.com

Most Recent

News & Insights

VIEW ALL
News & Updates, Thought Leadership
Jul 17, 2026

First published by Lexology. Authors: Sandhya Singh and Sampada Kapoor Modern sport is no longer merely an athletic competition; it is a multi-billion-dollar

Managing Ambush Marketing: Legal and Commercial Perspectives
News & Updates, Thought Leadership
Jul 08, 2026

‘First published on Enterprise IT World’ Author: Subroto Kumar Panda The digital ecosystem is undergoing an architectural segment change. For more

The Shift to Non-Human Digital Infrastructure: Orchestration, Self-Healing, and the Agentic Frontier
Thought Leadership
Jun 26, 2026

‘First published on WTR’By: Saif Khan and Prajjwal Kushwaha Legal framework Trademarks Act 1999 The Trademarks Act is the parent statutory regulation

India: courts adopt new ways to protect brand owners by permanent blocking of fraudulent domains and asset freezing 
News & Updates, Thought Leadership
Jun 16, 2026

First published by Lexology. Authors: Pravin Anand and Dr. Neeti Wilson Introduction India’s biodiversity is one of its greatest strategic assets.

India’s Biodiversity Framework at a Crossroads: Industry Perspectives on the Biological Diversity Act and ABS Regulations, 2025